Previous Article | Next Article ![]()
Journal of Virology, September 2000, p. 8277-8285, Vol. 74, No. 18
Cancer Research Institute and Department of
Molecular Biology and Biochemistry, University of California,
Irvine, California 92697
Received 19 April 2000/Accepted 16 June 2000
The Tax protein of human T-cell leukemia virus type 1 (HTLV-1)
enhances viral gene expression through sequences in the U3 region of
the viral long terminal repeat. These sequences consist of three
imperfect 21-bp repeats (TRE-1s) and a region between the
promoter-central and promoter-proximal 21-bp repeats (TRE-2). The
TRE-1s contain a core cyclic AMP response element (CRE) motif and can
be bound by CREB, ATF-1, ATF-2, and other members of the CREB-ATF
superfamily of transcription factors. Tax enhances CREB binding
to TRE-1 in vitro, and it promotes dimerization of CREB as well as
other bZIP proteins. Using ligation-mediated PCR on in vivo
dimethyl sulfate-treated HTLV-1-infected cell lines MT-2 and MT-4, we
have compiled a profile of protein occupancy in the HTLV-1 enhancer
sequences in the presence of high (MT-2) and low (MT-4) levels of
biologically active Tax I. The in vivo footprinting showed that all
three TRE-1s were bound by protein(s), but only in MT-2 cells. In MT-2
cells, all TRE-1s showed strong protection of the G residues in the
central CRE, and the footprints extended to differing degrees into the
GC-rich flanking sequences. This indicated Tax I-dependent
loading of transcription factors onto the HTLV-1 TRE-1s in vivo. In
vivo footprinting on TRE-2 indicated that this region was
bound by proteins regardless of the Tax I status of the cell line.
However, the presence of Tax I increased the extent and altered the
profile of proteins binding TRE-2 in vivo.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
In Vivo Genomic Footprinting of the Human T-Cell Leukemia Virus
Type 1 (HTLV-1) Long Terminal Repeat Enhancer Sequences in
HTLV-1-Infected Human T-Cell Lines with Different Levels of Tax
I Activity
*
Corresponding author. Mailing address: Cancer Research
Institute, Department of Molecular Biology and Biochemistry, University of California, Irvine, CA 92697. Phone: (949) 824-5554. Fax: (949) 824-4023. E-mail: hyfan{at}uci.edu.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|